Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs?

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 15 X posts from 13 X users, with an upper bound of 31,696 followers.

RT aHUSAllianceAct #Ethics of timely access to safe & effective #orphandrugs w/ policies that address #economic bu… https://t.co/lK1sBv0IW8

#Ethics of timely access to safe & effective #orphandrugs w/ policies that address #economic burden. #pharma https://t.co/CJtAeGHMv5

Ethics of timely access to #orphandrugs: Reconciling economic incentives & patients’ health needs? https://t.co/CJtAeGHMv5 @BioMedCentral

RT @aHUSAmerica: #Ethics of access to orphan drugs: Reconcile economics & patients needs? https://t.co/nkvIcKJsvK #raredisease #research #w…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.